Company: ALM
Filing Date: 2025-07-11
Form Type: F-10/A
Source: 0001641172-25-018741
Chunk: 4

Company: Almonty Industries Inc.
Filing Date: 2025-07-11
Form: F-10/A
Chunk 4
---
 Common Shares (including the Common Shares being distributed
hereunder) on the NASDAQ Capital Market (“NASDAQ”) under the symbol “ALM”.
Upon and subject to receipt of all requisite approvals and the commencement of trading of the Common Shares on the NASDAQ, trading
of the Common Shares on the OTCQX will cease. We have also applied to list the Offered Shares on the TSX. Listing will be subject to
the Company fulfilling all of the listing requirements of the TSX and NASDAQ, as applicable. On July 10, 2025, being the last
full-trading day prior to the date of this prospectus, the closing price of the Common Shares on the TSX was C$7.78, and the
closing price of the CDIs on the ASX was A$4.95 on July 4, 2025, being the last full-trading day prior to the trading halt of
CDIs on the ASX and not reflecting the Share Consolidation (as defined below). See “Recent Developments”.

| Price:                 
 US$l per Offered Share |

|                   |     | Public   
 Offering 
 Price    |      |     | Underwriters’ 
 Fee (1)       |      |     | Net             
 Proceeds to the 
 Company (2)     |      |
| Per Offered Share |     |          | US$l |     |               | US$l |     |                 | US$l |
| Total (3)         |     |          | US$l |     |               | US$l |     |                 | US$l |

Notes:

| (1) | The Company has agreed                                                                                                 
 to pay the Underwriters a cash commission (the “Underwriters’ Fee”)                                                    
 equal to l% of the aggregate purchase                                                                                  
 price paid by the Underwriters to the Company for the Offered Shares. See “Plan                                        
 of Distribution”.                                                                                                      |
| (2) | After deducting the Underwriters’ Fee, but before deducting                                                            
 the expenses of the Offering, which are estimated at US$l and                                                          
 will be paid by the Company from the proceeds of the Offering. The net proceeds payable to the Company will be derived 
 from the sale of the Offered Shares.                                                                                   |
| (3) | The Company has granted the Underwriters an over-allotment                                                             
 option (the “Over-Allotment Option”), exercisable in whole or in part, at any time and from time